Trypanosomes are protozoan agents of major parasitic diseases such as
Chagas' disease in South America and sleeping sickness of humans and n
agana disease of cattle in Africa. They ale transmitted to mammalian h
osts by specific insect vectors. Their life cycle consists of a succes
sion of differentiation and growth phases requiring regulated gene exp
ression to adapt to the changing extracellular environment. Typical of
such stage-specific expression is that of the major surface antigens
of Trypanosoma brucei, procyclin in the procyclic (insect) form and th
e variant surface glycoprotein (VSG) in the bloodstream (mammalian) fo
rm. In trypanosomes, the regulation of gene expression is effected mai
nly at posttranscriptional levels, since primary transcription of most
of the genes occurs in long polycistronic units and is constitutive.
The transcripts ale processed by transsplicing and polyadenylation und
er the influence of intergenic polypyrimidine tracts. These events sho
w some developmental regulation. Untranslated sequences of the mRNAs s
eem to play a pi-eminent role in the stage-specific control of individ
ual gene expression, through a modulation of mRNA abundance. The VSG a
nd procyclin transcription units exhibit particular features that are
probably related to the need for a high level of expression. The promo
ters and RNA polymerase driving the expression of these units resemble
those of the ribosomal genes. Their mutually exclusive expression is
ensured by controls operating at several levels, including RNA elongat
ion. Antigenic variation in the bloodstream is achieved through DNA re
arrangements ol alter-native activation of the telomeric VSG gene expr
ession sites. Recent discoveries, such as the existence of a novel nuc
leotide in telomeric DNA and the generation of point mutations in VSG
genes, have shed new light on the mechanisms and consequences of antig
enic variation.